GAMMA Investing’s Greenwich LifeSciences GLSI Stock Holding History

GAMMA Investing’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.22K	Buy	234 +176	+303%	+$2.93K	﹤0.01%	3721
2026 Q2	$1.36K	Buy	58 +31	+115%	+$754	﹤0.01%	3810
2026 Q1	$649	Buy	+27	New	+$704	﹤0.01%	3909
2025 Q2	–	Sell	-126	Closed	-$1.2K	–	3826
2025 Q1	$1.2K	Buy	+126	New	+$1.53K	﹤0.01%	3526

Other funds holding GLSI

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's GLSI Position: Q3 2026 in Review

GAMMA Investing increased its Greenwich LifeSciences (GLSI) stake by 303% in Q3 2026, buying an estimated $2.93K and bringing the position to 234 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

GAMMA Investing first reported a position in GLSI in Q1 2025 and has held it in 4 quarters since. 3 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

GAMMA Investing held 234 shares of Greenwich LifeSciences worth $4.22K as of Q3 2026.
GAMMA Investing bought 176 Greenwich LifeSciences shares in Q3 2026, an estimated $2.93K.
Greenwich LifeSciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3721 holding.
GAMMA Investing first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 4 quarters since.
3 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.